Measuring the Benefit of Performance Improvement and Decision Support
- 1 November 1999
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in American Journal of Medical Quality
- Vol. 14 (6), 262-269
- https://doi.org/10.1177/106286069901400606
Abstract
In an effort to provide high quality care in a more cost-effective manner, health care providers have found it necessary to implement a series of decision support strategies designed to improve outcomes of care. While each of these strategies has measurable benefits, each comes along with additional costs. As more and more technology becomes available and more labor resources are devoted to these efforts, it becomes crucial to be able to assess the costs and benefits of these programs. A return-on-investment methodology is used to assess the financial impact of service-related operating expenses compared to revenue gains from service delivery. However, unlike traditional return-on-investment models, in health care, benefits are frequently gained from cost avoidance rather than from revenue enhancement activities. This article will describe a methodology for measuring the direct and indirect costs and qualitative and quantitative benefits of decision support activities.Keywords
This publication has 21 references indexed in Scilit:
- A Computer Alert System to Prevent Injury From Adverse Drug EventsJAMA, 1998
- A Computer-Assisted Management Program for Antibiotics and Other Antiinfective AgentsNew England Journal of Medicine, 1998
- Collaborative Use of Informatics Among Hospitals to Benchmark Medication Use ProcessesThe Joint Commission Journal on Quality Improvement, 1997
- Using information management to implement a clinical resource management program.The Joint Commission Journal on Quality Improvement, 1997
- The Costs of Adverse Drug Events in Hospitalized PatientsJAMA, 1997
- Prevention of Nosocomial Bloodstream Infections: A National and International PriorityInfection Control & Hospital Epidemiology, 1996
- Incidence of Adverse Drug Events and Potential Adverse Drug EventsJAMA, 1995
- Costs of Potential Complications of Care for Major Surgery PatientsAmerican Journal of Medical Quality, 1995
- Financial Risk, Accountability and Outcome Management: Using Data to Manage and Measure Clinical PerformanceAmerican Journal of Medical Quality, 1994
- Nosocomial Bloodstream Infection in Critically III PatientsJAMA, 1994